AmerisourceBergen webinar. The broadcast has not started yet. For - - PowerPoint PPT Presentation

amerisourcebergen webinar
SMART_READER_LITE
LIVE PREVIEW

AmerisourceBergen webinar. The broadcast has not started yet. For - - PowerPoint PPT Presentation

Thank you for joining us for this AmerisourceBergen webinar. The broadcast has not started yet. For the audio portion of the meeting please dial US Toll free: 1.866.338.0150 Once connected, use participant passcode: 812 649 60# Sixth


slide-1
SLIDE 1

For the audio portion of the meeting please dial US Toll free: 1.866.338.0150 Once connected, use participant passcode: 812 649 60#

Thank you for joining us for this AmerisourceBergen webinar. The broadcast has not started yet.

slide-2
SLIDE 2

Sixth Manufacturer Townhall:

Responding to COVID-19

August 13, 2020

During the call, please submit questions via the chat function

  • r via email to: Solutions@amerisourcebergen.com
slide-3
SLIDE 3

Today’s Speakers

Heather Zenk

  • Sr. Vice President, Replenishment &

Secure Supply Chain Operations

Dave Picard

  • Sr. Vice President, Global Generics

Pharmaceuticals

08/14/2020 Conf idential 3

Jan Burkett

SVP of Global Specialty, Branded, & Consumer Products

Kenny Yu

Director of Pharmacy, 340B Program and Pharmacy Business Analytics, NYU Langone Health

Danielle O’Connell

Director Strategic Accounts, East Health Systems

Doug Cook

EVP & President – Commercialization Services & Animal Health

slide-4
SLIDE 4

Agenda 1

Opening Remarks

2

Voice of Customer – Health Systems

3

Commercialization Adaptations

4

Supply Chain Update

5

Q&A

6

Closing Remarks

08/14/2020 Conf idential 4

slide-5
SLIDE 5

Opening Remarks

Jan Burkett SVP of Global Specialty, Branded, & Consumer Products

08/1 4/20 5

slide-6
SLIDE 6

Health Systems Perspectives

08/14/20 20 6

Kenny Yu

Director of Pharmacy, 340B Program and Pharmacy Business Analytics, NYU Langone Health

Danielle O’Connell

Director Strategic Accounts, East Health Systems

slide-7
SLIDE 7

Commercialization Adaptation

08/14/2020 Conf idential 7

Doug Cook EVP & President – Commercialization Services & Animal Health

slide-8
SLIDE 8

Commercialization Services & Animal Health Businesses

08/14/2020 Conf idential 8

Adapting to support manufacturer partners, providers, patients, pet owners and policymakers during COVID-19

Global Clinical Trial Logistics & 3PL (World Courier and ICS) ▪ Increase in direct-to-patient volume ▪ Involvement in COVID-19 clinical trials ▪ June was record month for volume and weight ▪ Supported major health system with overflow storage to support treatment of COVID-19 patients Consulting & Field Reimbursement (Xcenda) ▪ Seamless transition to virtual client engagements ▪ Developed COVID-19 model and white paper to help health policy leaders make crucial decisions ▪ Launched COVID-19 disease state page to help payers make informed decisions on the disease landscape Patient Support Programs (Lash Group) ▪ Deployed a Universal Patient Portal – allows patients and providers to upload documents from their mobile/home devices ▪ Accelerating electronic Benefits Verification (eBV) leveraging AI ▪ Planning for a fully remote Annual Reverification – requires remote onboarding of 4,000 contractors Animal Health ▪ Launched new techy solutions to help veterinarians implement video and telehealth services ▪ Pet adoption remains high during pandemic ▪ Production animal market recovery will be slower as restaurant and hospitality industry reopens

slide-9
SLIDE 9

Supply Chain Update

08/14/2020 Conf idential 9

Heather Zenk

  • Sr. Vice President,

Replenishment & Secure Supply Chain Operations

slide-10
SLIDE 10

Supply Chain Update

08/14/2020 Conf idential 10

What we are seeing across the supply chain

Inventory

Continued stabilization

  • Physician based

businesses are starting to see normal course of business

  • 90-day refills following a

predictable flow

  • Hot zones implementing

lessons learned and amped up business continuity practices

Global Supply Chain

Risks:

  • Plasma donations

decreased

  • Individual country

constraints Opportunities:

  • Flu Vaccine
  • COVID Vaccine
slide-11
SLIDE 11

Policy Update

08/14/2020 Conf idential 11

Policy

  • MFN/IPI
  • 340b
  • Made in America
  • Importation
  • Rebate reform

Brad Tallamy

  • Sr. Director, Government Affairs
slide-12
SLIDE 12

Q & A

slide-13
SLIDE 13

Closing Remarks

08/14/2020 Conf idential 13

Dave Picard

  • Sr. Vice President, Global

Generics Pharmaceuticals

slide-14
SLIDE 14

We want your feedback.

We want to hear how AmerisourceBergen is doing to support you during the Covid-19 pandemic. Look for our email and please take the time to share your feedback via a 3-minute survey.

Conf idential

slide-15
SLIDE 15

We are united in our responsibility to create healthier futures.